Why didn’t the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?-Reference-Cited by-同舟云学术

Why didn’t the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?

Published:2023-05-03 Issue:7 Volume:57 Page:935-936
ISSN:0004-8674
Container-title:Australian & New Zealand Journal of Psychiatry
language:en
Short-container-title:Aust N Z J Psychiatry

Author:

Rossell Susan L¹²^ORCID,Meikle Sally E³,Williams Martin L¹,Castle David J⁴^ORCID

Affiliation:

1. Centre for Mental Health, School of Health Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia

2. Department of Psychiatry, St Vincent’s Hospital, Melbourne, VIC, Australia

3. Melbourne School of Psychological Science, The University of Melbourne, Melbourne, VIC, Australia

4. Tasmania Centre for Mental Health Service Innovation, University of Tasmania and Statewide Mental Health Service, Hobart, TAS, Australia

Funder

National Health and Medical Research Council

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/00048674231172691

Reference3 articles.

1. Psilocybin-assisted therapy for depression: How do we advance the field?

2. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm

3. Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depressive and Anxiety Disorders;International Encyclopedia of Public Health;2025

2. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first;Nature;2023-06-30